Epidermal Growth Factor Receptor as a Therapeutic Target in Colorectal Cancer-Reference-Cited by-同舟云学术

Epidermal Growth Factor Receptor as a Therapeutic Target in Colorectal Cancer

Published:2003-02 Issue:4 Volume:2 Page:246-251
ISSN:1533-0028
Container-title:Clinical Colorectal Cancer
language:en
Short-container-title:Clinical Colorectal Cancer

Author:

Cohen Roger B.

Publisher

Elsevier BV

Subject

Gastroenterology,Oncology

Reference56 articles.

1. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial;Douillard;Lancet,2000

2. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer;Saltz;N Engl J Med,2000

3. N9741: oxaliplatin (oxal) or CPT-11 + 5-fluorouracil (5FU)/leucovorin (LV) or oxal + CPT-11 in advanced colorectal cancer (CRC). Initial toxicity and response data from a GI Intergroup study;Goldberg;Proc Am Soc Clin Oncol,2002

4. Epidermal growth factor receptor immunohistochemical reactivity in patients with American Joint Committee on Cancer stage IV colon adenocarcinoma;Goldstein;Cancer,2001

5. Epidermal growth factorrelated peptides and their receptors in human malignancies;Salomon;Crit Rev Oncol Hematol,1995

Cited by 111 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. USP21-EGFR signaling axis is functionally implicated in metastatic colorectal cancer;2024-08-10

2. Prognostic Significance of EGFR, HER2, and c-Met Overexpression in Surgically Treated Patients with Adenocarcinoma of the Ampulla of Vater;Cancers;2024-08-03

3. Brexpiprazole Prevents the Malignant Progression of Human Colorectal Cancer Cells and Increases Its Sensitivity to EGFR Inhibition;Frontiers in Bioscience-Landmark;2024-05-06

4. Indoxyl sulfate contributes to colorectal cancer cell proliferation and increased EGFR expression by activating AhR and Akt;Biomedical Research;2024-03-22

5. Loss of ZNRF3/RNF43 Unleashes EGFR in Cancer;2024-03-19